H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR) Feb 4, 2026 07:09AM
Immunocore announces R&D leadership changes, promotes two executives Jan 30, 2026 07:00AM
Immunocore outlines 2026 strategic priorities focused on melanoma expansion Jan 9, 2026 07:01AM
UBS Assumes Immunocore Holdings (IMCR) at Buy Jan 7, 2026 12:43AM
Immunocore announces two executive departures Nov 28, 2025 07:03AM


Nov 6, 2025 08:12AM Immunocore Holdings plc (IMCR) Tops Q3 EPS by 24c
Oct 31, 2025 05:15AM Wells Fargo Starts Immunocore Holdings (IMCR) at Overweight
Oct 23, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Sep 16, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Aug 24, 2025 07:10PM Jefferies Assumes Immunocore Holdings (IMCR) at Buy
Aug 7, 2025 07:04AM Immunocore Holdings plc (IMCR) Misses Q2 EPS by 2c
Jul 28, 2025 05:52AM Immunocore Holdings (IMCR) PT Raised to $36 at Mizuho
Jun 3, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
May 27, 2025 12:52AM Deutsche Bank Starts Immunocore Holdings (IMCR) at Buy
May 7, 2025 09:49AM Immunocore Holdings plc (IMCR) Tops Q1 EPS by 49c
Apr 7, 2025 05:29AM Immunocore Holdings (IMCR) PT Lowered to $33 at Mizuho
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Mar 12, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Mar 11, 2025 12:52PM BTIG Reiterates Buy Rating on Immunocore Holdings (IMCR), PT $91
Mar 10, 2025 03:02PM Immunocore (IMCR) presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
Feb 26, 2025 07:29AM Immunocore Holdings plc (IMCR) Misses Q4 EPS by 23c
Jan 27, 2025 07:14AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Jan 10, 2025 07:02AM Immunocore (IMCR) announces strategic priorities
Jan 2, 2025 07:03AM Immunocore (IMCR) appoints Travis Coy as CFO, Head of Corporate Development
Dec 17, 2024 07:02AM Immunocore (IMCR) announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
Dec 13, 2024 05:37AM Morgan Stanley Downgrades Immunocore Holdings (IMCR) to Equalweight
Dec 3, 2024 06:00AM Immunocore (IMCR) announces reimbursement agreement in England for KIMMTRAK for the treatment of HLA-A*02:01-positive adults
Nov 11, 2024 05:47AM Mizuho Downgrades Immunocore Holdings (IMCR) to Neutral
Nov 6, 2024 09:12AM Immunocore Holdings plc (IMCR) Tops Q3 EPS by 50c
Oct 24, 2024 07:43AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Oct 24, 2024 03:51AM UBS Starts Immunocore Holdings (IMCR) at Sell
Sep 17, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Sep 16, 2024 10:00AM Oppenheimer Reiterates Outperform Rating on Immunocore Holdings (IMCR)
Sep 16, 2024 08:53AM TD Cowen Reiterates Buy Rating on Immunocore Holdings (IMCR)
Sep 12, 2024 07:54AM Mizuho Reiterates Outperform Rating on Immunocore Holdings (IMCR)
Aug 29, 2024 07:00AM Immunocore (IMCR) Announces CFO Transition
Aug 28, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
Aug 12, 2024 06:47AM Immunocore Holdings (IMCR) PT Lowered to $72 at Mizuho
Aug 8, 2024 07:13AM Immunocore Holdings plc (IMCR) Tops Q2 EPS by 25c